Insiders / Jackson Scott Thomas
Jackson Scott Thomas
CIK 1566617personinsider
Companies
5
First seen
Feb 27, 2015
Last activity
Jun 25, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Spero Therapeutics, Inc. · SPRO | 85,000 | — |
| Celator Pharmaceuticals Inc · CPXX | 35,593 | — |
| Macrogenics Inc · MGNX | 14,750 | — |
| Glycomimetics Inc · CBIO | 5,250 | — |
| Mural Oncology plc · MURA | — | — |
All securities held
9 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Celator Pharmaceuticals Inc | Common stock | 35,593 |
| Glycomimetics Inc | Common stock | 5,250 |
| Macrogenics Inc | Common stock | 14,750 |
| Spero Therapeutics, Inc. | Common stock | 85,000 |
Awards
| Company | Security | Shares |
|---|---|---|
| Macrogenics Inc | Restricted units | 3,750 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Celator Pharmaceuticals Inc | Options | 175,000 |
| Glycomimetics Inc | Options | 40,000 |
| Macrogenics Inc | Options | 22,000 |
| Spero Therapeutics, Inc. | Options | 20,000 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 25, 2015 | Grant Grant or award | CPXX Celator Pharmaceuticals Inc Common Stock | $0 | +23K +173.79% | 35,593 | low |
| May 18, 2021 | Grant Grant or award | CBIO Glycomimetics Inc Common Stock | $0 | +5K | 5,250 0.01% of shares | low |
| Jun 12, 2025 | Grant Grant or award | SPRO Spero Therapeutics, Inc. Common Stock | $0 | +20K +36.36% |